国产精品久久久久久亚洲,国产成人无码午夜视频在线观看 ,国产福利一区二区三区在线观看,国产av第一次处破,厨房玩弄丝袜人妻系列国产电影

上海滬震實(shí)業(yè)有限公司
掃一掃,手機(jī)逛起來(lái)
主營(yíng):ELISA試劑盒,人ELISA試劑盒,小鼠ELISA試劑盒,大鼠ELISA試劑盒,重組蛋白,金標(biāo)試劑盒,**組化試劑盒,標(biāo)準(zhǔn)品,單克隆抗體,多克隆抗體,生化試劑,生物培養(yǎng)基,原代細(xì)胞,細(xì)胞株,實(shí)驗(yàn)室耗材,動(dòng)物血清等產(chǎn)品
021-60345367
企業(yè)信息
10
  • 注冊(cè)時(shí)間:2015-11-06
  • 聯(lián)系人:游艷
  • 電話:021-60345367
  • 聯(lián)系時(shí),請(qǐng)說(shuō)明儀表網(wǎng)看到的
  • Email:shhzsw01@163.com
在線詢價(jià)
產(chǎn)品詳情

pHIS1525

  • 如果您對(duì)該產(chǎn)品感興趣的話,可以
  • 產(chǎn)品名稱:pHIS1525
  • 產(chǎn)品型號(hào):
  • 產(chǎn)品展商:HZbscience
  • 產(chǎn)品文檔:無(wú)相關(guān)文檔
  • 發(fā)布時(shí)間:2018-09-18
  • 在線詢價(jià)
簡(jiǎn)單介紹
pHIS1525的各批次質(zhì)粒菌株發(fā)貨前均經(jīng)過(guò)嚴(yán)格的多重驗(yàn)證,如存在質(zhì)量問(wèn)題,請(qǐng)?jiān)谑盏疆a(chǎn)品的三個(gè)月內(nèi)通知我司。收到pHIS1525后請(qǐng)短暫離心,取2μl轉(zhuǎn)化至對(duì)應(yīng)感受態(tài)中,挑取單克隆重新提取質(zhì)粒后使用。
產(chǎn)品描述

pHIS1525載體基本信息

載體名稱: pHIS1525
質(zhì)粒類型: 巨大芽孢桿菌表達(dá)載體
高拷貝/低拷貝: --
啟動(dòng)子: --
克隆方法: 多克隆位點(diǎn),限制性內(nèi)切酶
載體大小: 7402 bp
5' 測(cè)序引物及序列: --
3' 測(cè)序引物及序列: --
載體標(biāo)簽: 6xHis
載體抗性: 氨芐青霉素四環(huán)素
篩選標(biāo)記: 四環(huán)素
備注: --
產(chǎn)品目錄號(hào): --
穩(wěn)定性: --
組成型: --
病毒/非病毒: --

pHIS1525載體質(zhì)粒圖譜和多克隆位點(diǎn)信息

pHIS1525載體圖譜

pHIS1525載體簡(jiǎn)介

Plasmids pHIS1522/pHIS1525 both contain the strong xylA promoter (PxylA)
originating from Bacillus megaterium. Transcription from this promoter is xylose
inducible (after xylose addition, the xylose repressor coded by the xylR gene on
the plasmids is released from PxylA and transcription is initiated). The most
convenient cloning sites for insertion of DNA fragments carrying heterologous
genes are located in an open reading frame (orf1) under control of the xyloseinducible
promoter PxylA (15 unique restriction sites; see sequence). Therefore, any
protein can be expressed using one out of three functionally different fusion
strategies.
A transcriptional fusion requires that the gene of interest carries its own ribosome
binding sequence (RBS) and translation initiation codon. Such a DNA fragment
can be fused into any of the available restriction sites within orf1. Whether the
resulting transcriptional fusion leads to expression of the gene of interest, which
is independent from orf1 expression, depends on the location of the created orf1
stop codon with respect to the start codon of the gene of interest. lf these are close
together, translational coupling may occur, in which the ribosomes translating the
orf1 reading frame would terminate at its stop codon, creating a locally high
concentration of ribosomes, so that translation initiation at the new start codon
would be more efficient compared to a construct in which the orf1 translation
terminates farther away from the start codon.
On the other hand, if the orf1 reading frame continues for a long distance into the
reading frame of the gene of interest, the ribosomes translating the created orf1
fusion protein might inhibit initiation of translation of the protein of interest.
Therefore, it is advisable to pay attention to placement of a stop codon when
constructing the gene fusion. Taken together, although a transcriptional or operon
fusion is constructed, the efficient translation of the orf1 reading frame, and any
fusion thereof created by the insertion, is likely to, positively or negatively,
influence the translation efficiency of the gene of interest.
Alternatively, a truncated version of the gene of interest, lacking its own start
codon, may be fused in frame to the orf1 reading frame on pHIS1522/pHIS1525
to create a translational or protein fusion. This will result in expression of a chimeric
protein consisting of up to 18 amino acids specified by the orf1 encoding
sequence, followed by the sequence encoded by the gene of interest.
Using the BsrGI restriction site directly before the ATG start codon enables cloning
without changing the N-terminus of the protein of interest. pHIS1525 contains a
sequence encoding the B. subtilis extracellular esterase (LipA) and allows cloning
of target genes directly after the signal peptidase restriction site using the Kas I,
Nar I, or SfoI restriction sites.
It is important to note that the multiple cloning site and its reading frame are
identical in pHIS1522 and pHIS1525 starting from BglII. Hence, a parallel
cloning strategy of the gene of interest in pHIS1522 for intracellular and in
pHIS1525 for extracellular production is possible. The 6xHis sequence upstream
the MCS allows convenient purification and detection of the expressed Histagged
target proteins. For expression of target proteins without a 6xHis tag,
suitable plasmid constructs (pMM1522 & pMM1525) are also available. 

pHIS1525載體序列

hz-4902R Calponin 1/2/3  鈣結(jié)合蛋白Calponin抗體
hz-4905R SORBS2/ArgBP2  精氨酸結(jié)合蛋白2抗體
hz-4906R SLC40A1/FPN1  細(xì)胞膜鐵轉(zhuǎn)運(yùn)蛋白FP1抗體
hz-4907R TGF beta 3  轉(zhuǎn)移生長(zhǎng)因子β3(TGFβ3)抗體
hz-4908R TGF beta 1/LAP  轉(zhuǎn)化生長(zhǎng)因子β(TGFβ)抗體
hz-4909R TGF beta 2  轉(zhuǎn)化生長(zhǎng)因子β2(TGFβ2)抗體
hz-4910R MCSF/M-CSF  巨噬細(xì)胞克隆刺激因子抗體
hz-4911R Reg3 beta  胰島β細(xì)胞生長(zhǎng)因子Reg IIIα 抗體
hz-4912R Reg3 gamma  胰島β細(xì)胞生長(zhǎng)因子Reg IIIγ抗體
hz-4913R ENPP1  核苷酸內(nèi)焦磷酸酶/磷酸二酯酶1抗體
hz-4915R ACCN1/BNaC1/ASIC2  腦鈉通道蛋白1抗體
hz-4916R CD44/HCAM/PGP1  CD44抗體
hz-4917R BGP/Osteocalcin  骨保護(hù)蛋白/骨鈣素抗體
hz-4918R ChRM3/Acetylcholine receptor(M3)  毒蕈堿型乙酰膽堿受體M3抗體
hz-4919R MSH3  錯(cuò)配修復(fù)蛋白3抗體
hz-4937R Cystatin A  胱抑素A/半胱氨酸蛋白酶抑制劑A抗體
hz-4938R SDF-1/CXCL12  基質(zhì)細(xì)胞衍生因子1抗體
hz-4940R Metallothionein 3  金屬硫蛋白3抗體
hz-4942R HIV1 p55+p24+p17  艾滋病病毒抗體
hz-4943R MPO/Myeloperoxidase  髓過(guò)氧化物酶抗體
hz-4944R SETBP1  SET結(jié)合蛋白1抗體
hz-4948R Bacillus anthraci protein  炭疽桿菌菌體蛋白抗體

關(guān)于我們| 易展動(dòng)態(tài)| 易展榮譽(yù)| 易展服務(wù)| 易家文化| 英才集結(jié)號(hào)| 社會(huì)責(zé)任| 聯(lián)系我們

備案號(hào):粵ICP備11010883號(hào)| 公安機(jī)關(guān)備案號(hào):44040202000312| 版權(quán)問(wèn)題及信息刪除: 0756-2183610  QQ: 服務(wù)QQ

Copyright?2004-2017  珠海市金信橋網(wǎng)絡(luò)科技有限公司 版權(quán)所有

行業(yè)網(wǎng)站百?gòu)?qiáng)獎(jiǎng)牌 搜索營(yíng)銷*有價(jià)值獎(jiǎng) 中小企業(yè)電子商務(wù)**服務(wù)商
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),易展儀表展覽網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。

滬公網(wǎng)安備 31011702004356號(hào)